A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 39/02 (2006.01) A61K 39/08 (2006.01)
Patent
CA 2550108
The invention provides active and passive immunization methods for preventing and treating Clostridium Difficile infection, which involve percutaneous administration of C. difficile toxin-neutralizing polyclonal immune globulin, C. difficile toxoids, or combinations thereof. Also provided by the invention are C. difficile toxoids, C. difficile toxin-neutralizing polyclonal immune globulin, and methods of identifying subjects that produce C. difficile toxin- neutralizing polyclonal immune globulin.
L'invention concerne des méthodes d'immunisation active et passive pour prévenir et traiter l'infection à Clostridium difficile, consistant à administrer par voie percutanée l'immunoglobuline polyclonale neutralisant les toxines de C. difficile, des toxoïdes de C. difficile ou des combinaisons de ceux-ci. Cette invention concerne également des toxoïdes de C. difficile, l'immunoglobuline polyclonale neutralisant les toxines de C. difficile et des méthodes d'identification de patients qui produisent l'immunoglobuline polyclonale neutralisant les toxines de C. difficile.
Giannasca Paul J.
Lei Wende
Monath Thomas P.
Thomas William D. Jr.
Zhang Zhenxi
Acambis Inc.
Mbm Intellectual Property Law Llp
Sanofi Pasteur Biologics Co.
LandOfFree
Passive immunization against clostridium difficile disease does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Passive immunization against clostridium difficile disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Passive immunization against clostridium difficile disease will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2065831